SFSIG
IART icon

San Francisco Sentry Investment Group’s Integra LifeSciences IART Stock Holding History

San Francisco Sentry Investment Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,200
Closed -$153K – 922
2017
Q4 		$153K Hold
3,200
– – 0.04% 296
2017
Q3 		$162K Hold
3,200
– – 0.05% 277
2017
Q2 		$174K Buy
+3,200
New +$153K 0.06% 244

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

San Francisco Sentry Investment Group's IART Position: Q1 2018 in Review

San Francisco Sentry Investment Group sold out of Integra LifeSciences (IART) in Q1 2018, closing a stake of 3,200 shares — an estimated $153K sold.

San Francisco Sentry Investment Group first reported a position in IART in Q2 2017 and held it in 3 quarters. The position peaked at $174K in Q2 2017. 235 funds tracked by Wall St. Rank hold IART as of Q1 2018.

  • San Francisco Sentry Investment Group reported no remaining Integra LifeSciences position as of Q1 2018 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 3,200 Integra LifeSciences shares in Q1 2018, an estimated $153K.
  • San Francisco Sentry Investment Group first reported a position in Integra LifeSciences in Q2 2017 and held it in 3 quarters.
  • San Francisco Sentry Investment Group's Integra LifeSciences position peaked at $174K in Q2 2017.
  • 235 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2018, filed 4 May 2018.